Comparative Effectiveness Research in Integrative Oncology.

• Witt CM Institute for Complementary and Integrative Medicine, University of Zurich and University Hospital Zurich, Zurich, Switzerland; Institute for Social Medicine, Epidemiology and Health Economics, Charité, Universitätsmedizin, Berlin, Germany; Center for Integrative Medicine, University of Maryland School of Medicine, Baltimore, MD; RAND Corporation, Santa Monica, CA; Center for Medical Technology Policy, Baltimore, MD.
• Herman PM Institute for Complementary and Integrative Medicine, University of Zurich and University Hospital Zurich, Zurich, Switzerland; Institute for Social Medicine, Epidemiology and Health Economics, Charité, Universitätsmedizin, Berlin, Germany; Center for Integrative Medicine, University of Maryland School of Medicine, Baltimore, MD; RAND Corporation, Santa Monica, CA; Center for Medical Technology Policy, Baltimore, MD.
• Tunis S Institute for Complementary and Integrative Medicine, University of Zurich and University Hospital Zurich, Zurich, Switzerland; Institute for Social Medicine, Epidemiology and Health Economics, Charité, Universitätsmedizin, Berlin, Germany; Center for Integrative Medicine, University of Maryland School of Medicine, Baltimore, MD; RAND Corporation, Santa Monica, CA; Center for Medical Technology Policy, Baltimore, MD.

Biomedical Research

Cost-Benefit Analysis

Humans

Integrative Oncology

Neoplasms

Outcome Assessment, Health Care